Edition:
United States

Medigen Biotechnology Corp (3176.TWO)

3176.TWO on Gre Tai Securities Market of Chinese Taipei

36.80TWD
17 Nov 2017
Change (% chg)

NT$-0.25 (-0.67%)
Prev Close
NT$37.05
Open
NT$37.20
Day's High
NT$37.50
Day's Low
NT$36.60
Volume
177
Avg. Vol
426,056
52-wk High
NT$84.50
52-wk Low
NT$36.00

Chart for

About

MEDIGEN BIOTECHNOLOGY CORP. is engaged in the research and development of new drugs and the testing of nucleic acids. It involves in the licensing of technologies, the provision of technical services and the testing of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.57
Market Cap(Mil.): NT$5,138.30
Shares Outstanding(Mil.): 138.69
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.06 15.80
EPS (TTM): -- -- --
ROI: -- -10.84 12.07
ROE: -- -39.67 16.02

Earnings vs. Estimates